Best Life Sciences Platforms and Tools Companies in Tokyo, Japan
The 60 best Life Sciences Platforms and Tools companies in Tokyo, Japan in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: PHC Holdings.
Our analysis of 50 Life Sciences Platforms and Tools companies
$4.8b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Platforms and Tools companies in Tokyo
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | 3-D Matrix Peptide-based biomaterials for life science research | — | — | 47 | Keiji Nagano CEO | PHPLaravelNginx+7 | 371 patents Peptide-based bioinks and amphiphilic peptide nanostructures for tissue engineering and drug delivery | — |
| 2 | AbbVie Developer of small molecule-based drug for multiple diseases | — | — | 1,500 | Richard Gonzalez CEO | Adobe Experience ManagerJavaYouTube+19 | — | — |
| 3 | AI Pharma Proprietary AI-based drug discovery platform | — | — | — | Hitoshi Hasegawa CEO | — | 826 patents Advanced pharmaceutical formulations and delivery systems, including self‑emulsifying and biologic extracts. | — |
| 4 | ALDOCK Provider of liquid biopsy tests for cancer diagnostics | — | — | 2 | Shingo Mabuchi CEO | — | — | — |
| 5 | BEX Manufacturer of gene introduction device | — | — | — | Toshiyuki Moriizumi CEO | Node.jsReactNext.js+11 | 26 patents Nucleic‑acid editing reagents and delivery electrodes for biotech applications | — |
| 6 | BML Provider of clinical analytical testing services | — | — | 9,005 | — | YouTubeApache HTTP ServerAmazon Web Services+5 | 43 patents Stabilized clinical diagnostic assay kits and reagents for biomarkers and viral detection | — |
| 7 | Cell Bank Provider of cell storage and regenerative-based services | — | — | — | Motoharu Hojo CEO | Apache HTTP ServerTikTok PixelGoogle Analytics+5 | 5 patents Cryopreservation methods for tissue-derived cells used in cell therapy and biobanking | — |
| 8 | Clio Developer of technology for isolation and purification of Muse cells | — | — | 240 | Satoshi Morimoto President & CEO | — | 43 patents Regenerative therapies using pluripotent and MUSE stem cells for cardiac and kidney repair | — |
Top 12 Life Sciences Platforms and Tools companies in Tokyo
#1
Seed · Chiyoda City, Tokyo · founded 2024$2.6Mraised▾
Developer of hydrogel technology related to biomaterials and medical applications. The company specializes in developing bio-materials using Ameba Hydrogel technology for environmental, chemical, and medical applications based on life science and bioengineering.
- Apr 2026Seed$1.3M
- Feb 2024Seed$1.3M
#2
Series C · Bunkyo, Tokyo · founded 2016 · 33 employees$83.2Mraised▾
Developer of cell sorting and single cell profiling platforms. The business provides tools for cell therapy, disease profiling, and drug discovery applications. The platforms combine fluorescence flow cytometry with morphological profiling and artificial intelligence. The business also offers related consumables and instrument services.
- Aug 2024Series C$14.9M
- Nov 2023Series C$24M
- Nov 2023Grant (prize money)—
- May 2021Series B$26M
#3
Public · Tokyo, Tokyo · founded 1969 · 3 employees$182.3Mraised▾
Provider of devices and services for life science research. It is developing test analysis devices, healthcare IT solutions, and instruments for the life sciences industry. It also provides drug delivery solutions and medical record systems.
#4
Series D · Minato City, Tokyo · founded 2009 · 74 employees$111Mraised▾
Developer of spectrometry platforms for industrial process control, life science research. The company’s platforms harness spectrometry technologies with advanced analytics to generate actionable results. These platforms apply to applications across multiple industries. The company offers in-situ metrology for semiconductor manufacturing and multiplex testing.
- May 2021Series D$50M
- Aug 2019Series C$33M
- Jul 2016Series B$16M
- Aug 2014Series A$8M
#5
Seed · Shinjuku City, Tokyo · founded 2023$1.2Mraised▾
Developer of microfluidic devices for the detection of ultra-trace proteins. The company is working on the development of a compact benchtop detection system using microfluidic device that can detect ultra-trace proteins by utilizing the "TN-cyclon"(improved enzymatic cycling method).
- Nov 2024Seed$1.2M
#6
Series A · Minato City, Tokyo · founded 2019$4.7Mraised▾
Digital molecular modelling tool for drug development. The company has developed a platform that assists in calculating compound structures, enzymatic reactions, and more. It also has features for enzyme screening, bio-retrosynthesis and more.
- Apr 2024Series A$4.7M
#7
Series A · Bunkyo, Tokyo · founded 2015 · 7 employees$5.5Mraised▾
Cellfiber is a provider of cell fiber technology-based solutions. Cells processed into a fiber can be treated as a standardized fibrous part and can be assembled into various structures using living cells. The company is developing this technology to increase the efficiency of cell cultures and to create artificial biomaterials.
- Nov 2023Series A$5.5M
#8
Acquired · Tokyo, Tokyo · founded 2018 · 10 employees$10.9Mraised▾
Developer of technologies for DNA synthesis and amplification. The company has an OriCiro Cell-Free Cloning System which is composed of OriCiro Assembly Kit and OriCiro Amp Kit that enables cell-free assembly and amplification of circular DNA molecules.
- Jun 2022Series B—
- Jul 2021Series B$7.3M
- Jul 2021Conventional Debt$1.8M
- Apr 2019Series A$3.6M
#9
Seed · Koganei, Tokyo · founded 2005$1.3Mraised▾
On-chip Biotechnologies develops cell sorters based on microfluidic chip technology. The company has developed cell sorter using disposable microfluidic chips for the damage-free and contamination-free cell sorting. The technology enables individual cells analysis at the laser interrogation point ( producing liquid pulses) which makes the difference from a conventional flow cytometry system.
- May 2024Seed$1.3M
#10
Series C · Tokyo, Tokyo · founded 2013 · 33 employees$11.7Mraised▾
Provider of AI-based platform for drug discovery and design. The company uses Next Generation Sequencing and Molecular Biology technology for the discovery and detection of antibody molecules.
- Aug 2021Series C$7.2M
- Dec 2018Series B$2.5M
- 2016Grant (prize money)—
- Sep 2014Series A$2M
#11
Series A · Koto City, Tokyo · founded 2018 · 8 employees$3.4Mraised▾
Developer of cell cytometry and cell sorting platforms for life science experts. The company utilizes various technologies to develop various tools such as high-speed automatic microscope (SHIGI) and image activation cell sorter (ENMA) to understand and widely utilize cells and to diagnose, analyze, and process cells.
- Jun 2023Series A$2.9M
- Mar 2021Seed$562.8K
#12
Public · Bunkyo, Tokyo · founded 2010 · 22 employees$16.6Mraised▾
Developer of 3D tissue engineering technology. The flagship 3D bioprinter Regenova is used for manufacturing 3D tissues and organs. Another device Spike automatically assembles spheroids into any desired 3D shape. This robotic 3D bioprinter helps in developing regenerative medicines and drug discovery.
- Feb 2015Series B$11.8M
- Jan 2013Series A$4.8M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Platforms and Tools coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Bioinformatics in Tokyo is moving
A read on the academic research around Bioinformatics in Tokyo — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 252 papers.
Led by University of Tokyo, Tokyo's institutions optimistically research genomics, RNA mechanisms, and single-cell transcriptomics, with CRISPR engineering dominating recent breakthrough-focused bioinformatics output.
- The University of Tokyo147
- Tokyo University of Science21
- Institute of Science Tokyo17
- Tokyo Institute of Technology15
- Tokyo Medical and Dental University11
- Gene2→24
- Genome2→17
- Sequence (biology)1→9
- Phylogenetic tree1→4
- Genome1→3
- Disease3
- Extracellular vesicles3
- Computational biology2
- Extracellular vesicle2
- Gene expression profiling2
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.